Media
Media Releases and Announcements
Centre for Innovative Cancer Research cuts time between discovery and application
OTTAWA, June 29, 2011 — The University of Ottawa is honoured to be a major partner in the new Centre for Innovative Cancer Research (CICR) — a uniquely designed laboratory at the Ottawa Hospital Research Institute that will significantly speed-up development and testing of new cancer therapies.
The $15.8 million facility, which occupies one floor of a newly added wing at The Ottawa Hospital Cancer Centre, is equipped with state of the art devices to analyze cancer cells at the molecular level and develop and test new treatments in laboratory models.
Up until now, there could be a wait of ten year or more before major research discoveries reached patients for testing. However, because of its novel approach to clinical and laboratory research, the Centre is expected to reduce that time by half, or more in some cases.
Additionally, the CICR will play a large role in providing advanced training opportunities for students from the University of Ottawa.
The Centre for Innovative Cancer Research was built and equipped through a $6.3M grant from the Canada Foundation for Innovation. An additional $9.5M was provided by generous donors in the community through The Ottawa Hospital Foundation.
Read the Ottawa Hospital Research Institute’s press release
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the University’s faculties of Medicine and Health Sciences. The OHRI includes more than 1,500 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Visit the OHRI website.
About the University of Ottawa
The University of Ottawa, one of Canada’s top research-intensive universities, is dedicated to winning the battle against cancer. We are committed to excellence and encourage an interdisciplinary approach to knowledge creation that attracts the best academic talent from across Canada and around the world.
